Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, Type 2 AND Metformin”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01747083
What this trial is testing

Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)

Who this might be right for
Type 2 Diabetes
LG Life Sciences 24
Large-scale testing (Phase 3)Study completedNCT00362323
What this trial is testing

Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO

Who this might be right for
Dyslipidemia/Glucose Metabolism Disorder
Solvay Pharmaceuticals 482
Large-scale testing (Phase 3)Study completedNCT01682759
What this trial is testing

The Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 751
Not applicableStudy completedNCT01364350
What this trial is testing

TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study

Who this might be right for
Diabetes Mellitus Type 2 in Obese
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 550
Large-scale testing (Phase 3)Study completedNCT02551874
What this trial is testing

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 650
Large-scale testing (Phase 3)Study completedNCT00327015
What this trial is testing

BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Who this might be right for
Diabetes
AstraZeneca 1,306
Large-scale testing (Phase 3)Study completedNCT04039503
What this trial is testing

Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 475
Testing effectiveness (Phase 2)Study completedNCT03922750
What this trial is testing

A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 154
Testing effectiveness (Phase 2)Study completedNCT01071850
What this trial is testing

Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Astellas Pharma Inc 412
Post-approval studies (Phase 4)Study completedNCT02243176
What this trial is testing

24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 689
Testing effectiveness (Phase 2)Study completedNCT02895750
What this trial is testing

Efficacity and Safety of Metformin XR in CKD Stage 1 to 3

Who this might be right for
Renal Insufficiency, Chronic
Centre Hospitalier Universitaire, Amiens 12
Testing effectiveness (Phase 2)Study completedNCT03655535
What this trial is testing

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

Who this might be right for
Type2 Diabetes Mellitus
Boston Therapeutics 66
Post-approval studies (Phase 4)Study completedNCT01356381
What this trial is testing

Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Novartis Pharmaceuticals 43
Large-scale testing (Phase 3)Study completedNCT00822211
What this trial is testing

Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
Novartis 404
Large-scale testing (Phase 3)Study completedNCT03332771
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 954
Large-scale testing (Phase 3)Study completedNCT00744367
What this trial is testing

Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 326
Post-approval studies (Phase 4)Study completedNCT02526615
What this trial is testing

Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes

Who this might be right for
Insulin SensitivityType 2 Diabetes
Turku University Hospital 48
Post-approval studies (Phase 4)Study completedNCT02512523
What this trial is testing

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 39
Not applicableUnknownNCT04194515
What this trial is testing

Gut Microbiota and Bile Acids in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2MetforminYH1
Chang Gung Memorial Hospital 50
Large-scale testing (Phase 3)Study completedNCT00772174
What this trial is testing

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 418
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation